Camarda Financial Advisors buys $3,088,991 stake in Aetna Inc (AET)

Aetna Inc (AET) : Camarda Financial Advisors scooped up 19 additional shares in Aetna Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 11, 2016. The investment management firm now holds a total of 25,832 shares of Aetna Inc which is valued at $3,088,991.Aetna Inc makes up approximately 1.88% of Camarda Financial Advisors’s portfolio.

Other Hedge Funds, Including , Rhumbline Advisers boosted its stake in AET in the latest quarter, The investment management firm added 23,002 additional shares and now holds a total of 601,346 shares of Aetna Inc which is valued at $71,908,955. Aetna Inc makes up approx 0.20% of Rhumbline Advisers’s portfolio.Private Advisor Group boosted its stake in AET in the latest quarter, The investment management firm added 1,968 additional shares and now holds a total of 6,705 shares of Aetna Inc which is valued at $793,336. Aetna Inc makes up approx 0.03% of Private Advisor Group’s portfolio.Oppenheimer Co Inc boosted its stake in AET in the latest quarter, The investment management firm added 1,011 additional shares and now holds a total of 13,242 shares of Aetna Inc which is valued at $1,578,314. Aetna Inc makes up approx 0.05% of Oppenheimer Co Inc’s portfolio.Essex Financial Services reduced its stake in AET by selling 774 shares or 5.05% in the most recent quarter. The Hedge Fund company now holds 14,556 shares of AET which is valued at $1,676,997. Aetna Inc makes up approx 0.39% of Essex Financial Services’s portfolio.

Aetna Inc closed down -0.38 points or -0.32% at $119.77 with 8,65,467 shares getting traded on Tuesday. Post opening the session at $120.31, the shares hit an intraday low of $119.58 and an intraday high of $120.77 and the price fluctuated in this range throughout the day.Shares ended Tuesday session in Red.

On the company’s financial health, Aetna Inc reported $2.21 EPS for the quarter, beating the analyst consensus estimate by $ 0.09 according to the earnings call on Aug 2, 2016. Analyst had a consensus of $2.12. The company had revenue of $15952.30 million for the quarter, compared to analysts expectations of $15762.79 million. The company’s revenue was up 4.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.05 EPS.

Many Wall Street Analysts have commented on Aetna Inc. Aetna Inc was Initiated by Bernstein to “Outperform” on Jun 16, 2016.

Aetna Inc. is a diversified health care benefits company. The Company offers a range of traditional voluntary and consumer-directed health insurance products and related services. The Company’s operations are conducted in three business segments: Health Care Group Insurance and Large Case Pensions. The Company’s Health Care segment includes medical pharmacy benefit management services dental behavioral health and vision plans. The Company’s Group Insurance segment’s products consist primarily of Life Insurance Products Disability Insurance Products and Long-Term Care Insurance Products. The Company’s Large Case Pensions segment manages a variety of retirement products (including pension and annuity products) primarily for tax-qualified pension plans. The Company’s customers include employer groups individuals college students part-time and hourly workers health plans health care providers Governmental units Government-sponsored plans labor groups and expatriates.

Leave a Reply

Aetna Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Aetna Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.